4.8 Review

Calcium-based biomaterials for diagnosis, treatment, and theranostics

期刊

CHEMICAL SOCIETY REVIEWS
卷 47, 期 2, 页码 357-403

出版社

ROYAL SOC CHEMISTRY
DOI: 10.1039/c6cs00746e

关键词

-

资金

  1. Shenzhen University
  2. National Science Foundation of China [51573096, 81401465, 51703132, 31771036]
  3. Basic Research Program of Shenzhen [JCYJ20170412111100742, JCYJ20160422091238319]
  4. Postdoctoral Science Foundation of China [2017M612727]
  5. National Postdoctoral Program for Innovative Talents [BX201600111]

向作者/读者索取更多资源

Calcium-based (CaXs) biomaterials including calcium phosphates, calcium carbonates, calcium silicate and calcium fluoride have been widely utilized in the biomedical field owing to their excellent biocompatibility and biodegradability. In recent years, CaXs biomaterials have been strategically integrated with imaging contrast agents and therapeutic agents for various molecular imaging modalities including fluorescence imaging, magnetic resonance imaging, ultrasound imaging or multimodal imaging, as well as for various therapeutic approaches including chemotherapy, gene therapy, hyperthermia therapy, photodynamic therapy, radiation therapy, or combination therapy, even imaging-guided therapy. Compared with other inorganic biomaterials such as silica-, carbon-, and gold-based biomaterials, CaXs biomaterials can dissolve into nontoxic ions and participate in the normal metabolism of organisms. Thus, they offer safer clinical solutions for disease theranostics. This review focuses on the state-of-the-art progress in CaXs biomaterials, which covers from their categories, characteristics and preparation methods to their bioapplications including diagnosis, treatment, and theranostics. Moreover, the current trends and key problems as well as the future prospects and challenges of CaXs biomaterials are also discussed at the end.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据